Document is current

Article History

Received: 1 August 2025

Accepted: 1 November 2025

First Online: 1 December 2025

Declarations

:

: This work was supported by the Cooperatio Program, research area INDI.This study was financially and materially supported by 3-D Matrix Europe SAS, Caluire-et-Cuire, France. The sponsor had no role in the design, conduct, data collection, analysis, or interpretation of the study. The authors declare no personal financial or institutional conflicts of interest.Dr. Ilja Tachecí reports institutional funding from 3-D Matrix Europe SAS and the Cooperatio Program, research area INDI, for this study. He received travel support (SuppMed, 3-D Matrix Europe SAS) and serves as President of the Czech Society of Gastroenterology (unpaid role), received speaker honoraria from PRO.MED.CS Praha a.s., Novantin s.r.o. and tutor honoraria from Olympus.Dr. Štěpán Šembera reports lecture honoraria from PRO.MED.CS Praha a.s., traineeship support from ESGE training grant, Endowment Fund of the Czech Hepatology Society and Endowment Fund HKMED, travel support from Celltrion Healthcare CZ and PRO.MED.CS Praha a.s.Dr. Kateřina Geisler Vejvalková has no conflicts of interest or financial ties to disclose.Dr. Paula Morávková received travel support (AbbVie, Takeda).Dr. Věra Radochova has no conflicts of interest or financial ties to disclose.Dr. Dana Zimandlová has no conflicts of interest or financial ties to disclose.Dr. Aleš Ryška has served on advisory boards for Amgen, AstraZeneca, Bayer, BMS, Eli Lilly, Gilead, Merck, MSD, Pfizer, Pierre Fabre, Roche, and Sanofi; received speaker honoraria from Amgen, AstraZeneca, Bayer, BMS, Eli Lilly, Gilead, Merck, MSD, Pfizer, Pierre Fabre, and Roche; and travel support from Gilead, Pierre Fabre, and Sanofi. He is Immediate Past President of the European Society of Pathology (unpaid role).Dr. Jiri Cyrany received travel support from SuppMed and serves as a board member of the Czech Society of Gastroenterology (unpaid role).